Telomir Pharmaceuticals, Inc. (TELO) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.33 | +41.1% |
| 2024 | $-0.56 | -216.7% |
| 2023 | $0.48 | +1700.0% |
| 2022 | $-0.03 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.33 | +41.1% |
| 2024 | $-0.56 | -216.7% |
| 2023 | $0.48 | +1700.0% |
| 2022 | $-0.03 | — |